Apogee Therapeutics, Inc. Common Stock (APGE) Sentiment
30-day sentiment Neutral · ▼ cooling · as of 2026-11-08
APGE sentiment is neutral over the last 30 days and cooling from a month ago; there is no reading for today yet. Most of the conversation is on News and X. SentiSense tracks APGE sentiment daily across news and social media.
- Sentiment (30-day)
- Neutral
- Today's read
- No reading yet today
- Trend (30-day)
- Cooling
Where the conversation is happening
- News
- Bullish
- X
- Neutral
Related tickers
What's driving it
- AbbVie closes its $10.9 billion Apogee Therapeutics acquisition, adding a late-stage immunology pipeline
- AbbVie Acquires Apogee Therapeutics for $10.9 Billion in Cash
- AbbVie Acquires Apogee Therapeutics for $10.9 Billion
SentiSense tracks Apogee Therapeutics, Inc. Common Stock (APGE) sentiment daily. The live SentiSense Score, its history, and the per-source breakdown are on this page in the SentiSense app.
See how APGE's sector compares in the market sentiment heatmap